BIDDISCOMBE SIMON 4
4 · MICROVISION, INC. · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
MicroVision Exec Vice Chair Simon Biddiscombe Acquires 93,950 Shares
What Happened
Simon Biddiscombe, Executive Vice Chair and Director of MicroVision, acquired 93,950 shares of MicroVision common stock on March 15, 2026. The Form 4 reports a transaction value of approximately $50,000 (reported price $0.53/share); a filing footnote clarifies the purchase price was $0.5322 per share (the closing price on March 13, 2026). This was a purchase directly from the company under a Subscription Agreement.
Key Details
- Transaction date: March 15, 2026; reported on Form 4 filed March 16, 2026 (timely filing).
- Shares acquired: 93,950; reported amount: ~$50,000 (reported $0.53/share; footnote price $0.5322/share).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnotes: purchase made under a Subscription Agreement executed March 15, 2026; purchase price equals the March 13, 2026 closing price.
- Regulatory note: the purchase is stated to be intended as an exempt transaction under Rule 16b-3 (common exemption for certain insider transactions).
Context
This was a direct company sale to an insider (not an open-market buy) and is coded as an acquisition/award on the Form 4. The dollar amount is modest for insider purchases; purchases can be more informative than sales but do not by themselves prove future performance. The Rule 16b-3 exemption and the Subscription Agreement indicate this was a routine, approved insider acquisition rather than a market trade.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-03-15$0.53/sh+93,950$50,000→ 385,249 total
Footnotes (2)
- [F1]Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 93,950 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.
- [F2]The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.